FC
FLUOR CORP (FLR)·Q3 2025 Earnings Summary
Executive Summary
- Q3 2025 delivered strong adjusted results despite a large legal charge: adjusted EPS $0.68 (up 33% y/y) vs S&P Global consensus $0.45 — bold beat; revenue $3.37B missed consensus $4.20B due to a $653M Santos ruling recorded as a reduction to revenue . EPS estimate vs actual from S&P Global: 0.45 vs 0.68*; revenue estimate vs actual: $4.20B vs $3.37B*.
- Guidance raised: 2025 adjusted EBITDA to $510–$540M (from $475–$525M) and adjusted EPS to $2.10–$2.25 (from $1.95–$2.15); operating cash flow guidance increased to $250–$300M .
- Backlog stable at $28.2B with 82% reimbursable; new awards $3.3B (99% reimbursable) support forward visibility, with Energy Solutions headwinds offset by Urban and Mission momentum .
- Capital return accelerates: $70M repurchased in Q3; targeting an additional $800M through February (total ~$1.3B over 15 months), enabled by the structured NuScale stake monetization plan and $605M proceeds through early October .
Note: Values retrieved from S&P Global*.
What Went Well and What Went Wrong
What Went Well
- Adjusted EBITDA $161M (up 29% y/y) and adjusted EPS $0.68 (up 33% y/y); management emphasized “disciplined execution, a predominantly reimbursable portfolio, and a clear capital allocation strategy” .
- Urban Solutions momentum: revenue rose to $2.3B (from $1.9B), profit $61M; new awards $1.8B with strength in life sciences/mining, backlog up 8% y/y to $20.5B .
- Mission Solutions strength: new awards $1.3B including a six-year DOE Portsmouth extension (~$1.1B), with segment profit of $34M and favorable claim resolution on a completed weapons project .
What Went Wrong
- Santos ruling impact: $653M recorded as a revenue reversal in Energy Solutions, driving segment loss of $533M and consolidated segment loss of $439M; GAAP net loss attributable to Fluor was $697M .
- NuScale mark-to-market loss: $401M equity method loss and related tax complexities (e.g., valuation allowance release) weighed on GAAP results .
- Infrastructure headwinds: Urban Solutions reflected a $25M delay-related adjustment and G&A rose to $43M (+16% y/y) including $12M restructuring; Energy Solutions new awards fell to $222M, backlog declined y/y to $5.1B .
Financial Results
Quarterly Results (Q1 → Q3 2025)
Segment Breakdown – Q3 2025 vs Q3 2024
KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Despite continued short term uncertainty in some markets, we are well positioned with unmatched global engineering and construction expertise, disciplined execution, a predominantly reimbursable portfolio, and a clear capital allocation strategy.” — CEO Jim Breuer .
- “Based on the results from this quarter, we are increasing our 2025 adjusted EBITDA guidance to $510–$540 million and our adjusted EPS guidance to $2.10–$2.25.” — CFO John Regan .
- On Santos: “The $653 million charge… because it’s customer-related, was recorded as a reduction to revenue… we expect to send payment to Santos to enable the appeal process… negotiating with carriers to support the appeal and costs.” — CFO John Regan .
- On NuScale: “Our monetization plan ensures we can… deliver significant value… while also considering NuScale’s own capital-raising needs.” — CEO Jim Breuer ; “Monetization should begin… under a structured program to get the best NPV.” — CFO John Regan .
Q&A Highlights
- 2026 outlook: Management expects EBITDA “marginally better than 2025,” with Urban growth (metals/mining) and ES tailwinds from Mexico resumption; legacy projects burden easing .
- ES margins excluding Santos: Handovers and reserve reductions support normalized margins; CFO to “coalesce” around a figure, guided ~6% for CY25 .
- Santos funding: ~$600M expected funded from core operating cash — not NuScale proceeds; insurance tower contributions likely to improve .
- Data centers & power: Focus on large, complex hyperscaler campuses via strategic relationships; accelerated U.S. gas-fired power outreach; nuclear prospects evolving with technology partners .
- Backlog adjustments: Explanation of CFM-driven accounting effects leading to deferral of PGM in Q2; transparency on variable consideration changes .
Estimates Context
- Q3: Bold EPS beat; revenue miss driven by the Santos $653M reversal, with adjusted EBITDA $161M above consensus EBITDA $129.5M implied on adjusted basis (S&P’s “EBITDA” actual reflects GAAP EBITDA at -$469M due to the charge) .
Note: Values retrieved from S&P Global*.
Key Takeaways for Investors
- The quarter’s headline GAAP loss masks robust adjusted performance and raised guidance; the Santos charge is the principal driver of the reported shortfall, recorded directly against revenue .
- Urban and Mission segments provide near-term support: Urban revenue and awards surged; Mission won a six-year DOE Portsmouth extension and other federal work, underpinning stability .
- Energy Solutions headwinds are ebbing: Mexico JV collections ($800M in Q3, $300M in Oct) enable controlled ramp-up; ES margins guided ~6% ex Santos for CY25 .
- Capital return is a tangible catalyst: $800M targeted repurchases through February (total ~$1.3B over 15 months), supported by NuScale monetization program .
- Backlog quality is high (82% reimbursable) and stable (~$28.2B); new awards and backlog adjustments indicate continued conversion, albeit with award timing skewing into 2H 2026 .
- Watch upcoming Santos payment and insurance tower resolution; management expects carrier contributions to improve versus initial commitments .
- The narrative into 2026: award timing deferrals shift EBIT by ~four quarters, but management sees medium-term acceleration in Urban (metals/mining, life sciences) and power (gas, nuclear), plus potential LNG Canada Phase 2 .
Additional Data and Disclosures
- Q3 operating cash flow was $286M; full-year OCF guidance raised to $250–$300M .
- Backlog by segment at Sept 30, 2025: Urban $20.5B; Energy $5.1B; Mission $2.6B; Total $28.2B (82% reimbursable) .
- NuScale agreement details: conversion of remaining stake to Class A shares; structured monetization; completion targeted by end of Q2 2026 .
Disclaimer: Values retrieved from S&P Global* and company filings/transcripts as cited above.